Good Stuff "EM"...unfortunately, I got into around this time last year when "MEIP" was well above $4...I did go ahead and average down after reviewing the info regarding that failure...and it still sounds promising. Always the problem with these small pharma/bio plays...talk about being a spec...but, it pays off would be worth if things fall into place.
Keep up the informative news...could use it here. :)
News 
Market Data 
Discover 
